Vasculopatías congénitas
Barra lateral del artículo
Contenido principal del artículo
Resumen
.
Downloads
Detalles del artículo
Sección
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Cómo citar
Referencias
Blanchet AS, Cottin V, Cordier JF. Manifestations vasculaires pulmonaires de la maladie de Rendu-Osler. Presse Med. 2005;34(19 pt2):1487-95. DOI: https://doi.org/10.1016/S0755-4982(05)84210-1
Cole SG, Begbie ME, Wallace GMF, et al. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet. 2005;42:577-82. DOI: https://doi.org/10.1136/jmg.2004.028712
Fuchizaki U, Miroyamori H, Kitagawa S, et al. Hereditary haemorraghic telangiectasia (Rendu-Osler-Weber disease) . Lancet. 2003;362(9394):1490-94. DOI: https://doi.org/10.1016/S0140-6736(03)14696-X
García-Tsao G. Liver involvement in hereditary hemorrhagic telangiectasia (HTT). J Hepatol. 2007 Mar;46(3):499-507 DOI: https://doi.org/10.1016/j.jhep.2006.12.008
Goumans MJ, Valdimarsdottir G, Itoh S, et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell. 2003;12(4):817-28. DOI: https://doi.org/10.1016/S1097-2765(03)00386-1
Goumans M, Valdimarsdottir G, Itoh S, et al. Balancing the activation state of the endothelium via two distinct TGF-b type I receptors. EMBO J. 2002;21(7):1743-53. DOI: https://doi.org/10.1093/emboj/21.7.1743
Hiatjema T, Dish F, Overtoon TC, et al. Screening of family members of patients with hereditary hemorrhagic telangiectasia. Am J Med. 1995;99(5):519-24. DOI: https://doi.org/10.1016/S0002-9343(99)80229-0
Kikuchi K, Kowada M, Sasajima H. Vascular malformations of the brain in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease). Surg Neurol. 1994;41(5):374-80. DOI: https://doi.org/10.1016/0090-3019(94)90030-2
Kukulj S, Ivanovi-Herceg Z, Slobodnjak Z. Hereditary hemorrhagic telangiectasia or Rendu-Osler-Weber syndrome in the same family. Coll Antropol. 2000;24(1):241-7.
Morales Salas M, Ventura J, Ruíz Carmona E, et al. Management of epistaxis in Rendu-Osler-Weber disease. An Otorrinolaringol Ibero Am. 2001;28(3):281-91.
Pick A, Deschamps C, Stanson AW. Pulmonary arteriovenous fistula: presentation, diagnosis, and treatment. World J Surg. 1999;23(11):1118-22. DOI: https://doi.org/10.1007/s002689900634
Plauchu H, de Chadarévian JP, Bideau A, et al. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989;32(3):291-7. DOI: https://doi.org/10.1002/ajmg.1320320302
Sabba C, Pasculli G, Cirulli A, et al. Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease). Minerva Cardioangiol. 2002;50(3):221-38.
Shlovin CL, Guttmacher AE, Buscarani E, et al. Diagnostic criteria for hereditary hemorraghic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91(1):66-7 DOI: https://doi.org/10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P
Sotckx L, Raat H, Caerts B, et al. Transcatheter embolization of hepatic arteriovenous fistulas in Rendu-Osler-Weber disease: a case report and review of the literature. Eur Radiol. 1999;9(7):1434-7 DOI: https://doi.org/10.1007/s003300050865
Stuhrmann M, El Harith el HA. Hereditary hemorrhagic telangiectasia. Genetics, pathogenesis, clinical manifestation and management. Saudi Med J. 2007;28(1):11-21
Urness LD, Sorensen LK, Li DY. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet. 2000;26(3):328-31 DOI: https://doi.org/10.1038/81634